Nam et al., assessed the efficacy of an anti-TGFβ mAb in a transplantable 4T1 model of metastatic breast cancer and reported increased infiltration of T and NK cells, increased expression of NKG2D and cytotoxic granules, and enhanced CD8+ T cell-mediated anti-tumor responses [223]. Here, TGFB1 is linked to neoplasm.